Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease

Jae Seung Lee, Jin Won Huh, Eun Jin Chae, Joon Beom Seo, Seung Won Ra, Ji Hyun Lee, Eun Kyung Kim, Young Kyung Lee, Tae Hyung Kim, Woo Jin Kim, Jin Hwa Lee, Sang Min Lee, Sang Yeub Lee, Seong Yong Lim, Tae Rim Shin, Ho Il Yoon, Seung Soo Sheen, Yeon Mok Oh, Sang Do Lee

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and responses to therapies are highly variable. The aim of this study was to identify the predictors of pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD. A total of 127 patients with stable COPD from the Korean Obstructive Lung Disease (KOLD) Cohort, which were prospectively recruited from June 2005 to September 2009, were analyzed retrospectively. The prediction models for the FEV1, FVC and IC/TLC changes after 3 months of treatment with salmeterol/fluticasone were constructed by using multiple, stepwise, linear regression analysis. The prediction model for the FEV1 change after 3 months of treatment included wheezing history, pre-bronchodilator FEV1, post-bronchodilator FEV1 change and emphysema extent on CT (R = 0.578). The prediction models for the FVC change after 3 months of treatment included prebronchodilator FVC, post-bronchodilator FVC change (R = 0.533), and those of IC/TLC change after 3 months of treatment did pre-bronchodilator IC/TLC and post-bronchodilator FEV1 change (R = 0.401). Wheezing history, pre-bronchodilator pulmonary function, bronchodilator responsiveness, and emphysema extent may be used for predicting the pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD.

Original languageEnglish
Pages (from-to)379-385
Number of pages7
JournalJournal of Korean Medical Science
Volume26
Issue number3
DOIs
Publication statusPublished - 2011 Mar 1

Fingerprint

Bronchodilator Agents
Chronic Obstructive Pulmonary Disease
Lung
Respiratory Sounds
Emphysema
Therapeutics
Obstructive Lung Diseases
Salmeterol Xinafoate Drug Combination Fluticasone Propionate
Linear Models
Regression Analysis

Keywords

  • Adrenergic beta-Agonists
  • Chronic obstructive
  • Corticosteroids
  • Emphysema
  • Pulmonary disease
  • Respiratory function tests

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease. / Lee, Jae Seung; Huh, Jin Won; Chae, Eun Jin; Seo, Joon Beom; Ra, Seung Won; Lee, Ji Hyun; Kim, Eun Kyung; Lee, Young Kyung; Kim, Tae Hyung; Kim, Woo Jin; Lee, Jin Hwa; Lee, Sang Min; Lee, Sang Yeub; Lim, Seong Yong; Shin, Tae Rim; Yoon, Ho Il; Sheen, Seung Soo; Oh, Yeon Mok; Lee, Sang Do.

In: Journal of Korean Medical Science, Vol. 26, No. 3, 01.03.2011, p. 379-385.

Research output: Contribution to journalArticle

Lee, JS, Huh, JW, Chae, EJ, Seo, JB, Ra, SW, Lee, JH, Kim, EK, Lee, YK, Kim, TH, Kim, WJ, Lee, JH, Lee, SM, Lee, SY, Lim, SY, Shin, TR, Yoon, HI, Sheen, SS, Oh, YM & Lee, SD 2011, 'Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease', Journal of Korean Medical Science, vol. 26, no. 3, pp. 379-385. https://doi.org/10.3346/jkms.2011.26.3.379
Lee, Jae Seung ; Huh, Jin Won ; Chae, Eun Jin ; Seo, Joon Beom ; Ra, Seung Won ; Lee, Ji Hyun ; Kim, Eun Kyung ; Lee, Young Kyung ; Kim, Tae Hyung ; Kim, Woo Jin ; Lee, Jin Hwa ; Lee, Sang Min ; Lee, Sang Yeub ; Lim, Seong Yong ; Shin, Tae Rim ; Yoon, Ho Il ; Sheen, Seung Soo ; Oh, Yeon Mok ; Lee, Sang Do. / Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease. In: Journal of Korean Medical Science. 2011 ; Vol. 26, No. 3. pp. 379-385.
@article{421ca62aafca47aa984111f11b1efee1,
title = "Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease",
abstract = "Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and responses to therapies are highly variable. The aim of this study was to identify the predictors of pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD. A total of 127 patients with stable COPD from the Korean Obstructive Lung Disease (KOLD) Cohort, which were prospectively recruited from June 2005 to September 2009, were analyzed retrospectively. The prediction models for the FEV1, FVC and IC/TLC changes after 3 months of treatment with salmeterol/fluticasone were constructed by using multiple, stepwise, linear regression analysis. The prediction model for the FEV1 change after 3 months of treatment included wheezing history, pre-bronchodilator FEV1, post-bronchodilator FEV1 change and emphysema extent on CT (R = 0.578). The prediction models for the FVC change after 3 months of treatment included prebronchodilator FVC, post-bronchodilator FVC change (R = 0.533), and those of IC/TLC change after 3 months of treatment did pre-bronchodilator IC/TLC and post-bronchodilator FEV1 change (R = 0.401). Wheezing history, pre-bronchodilator pulmonary function, bronchodilator responsiveness, and emphysema extent may be used for predicting the pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD.",
keywords = "Adrenergic beta-Agonists, Chronic obstructive, Corticosteroids, Emphysema, Pulmonary disease, Respiratory function tests",
author = "Lee, {Jae Seung} and Huh, {Jin Won} and Chae, {Eun Jin} and Seo, {Joon Beom} and Ra, {Seung Won} and Lee, {Ji Hyun} and Kim, {Eun Kyung} and Lee, {Young Kyung} and Kim, {Tae Hyung} and Kim, {Woo Jin} and Lee, {Jin Hwa} and Lee, {Sang Min} and Lee, {Sang Yeub} and Lim, {Seong Yong} and Shin, {Tae Rim} and Yoon, {Ho Il} and Sheen, {Seung Soo} and Oh, {Yeon Mok} and Lee, {Sang Do}",
year = "2011",
month = "3",
day = "1",
doi = "10.3346/jkms.2011.26.3.379",
language = "English",
volume = "26",
pages = "379--385",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "3",

}

TY - JOUR

T1 - Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease

AU - Lee, Jae Seung

AU - Huh, Jin Won

AU - Chae, Eun Jin

AU - Seo, Joon Beom

AU - Ra, Seung Won

AU - Lee, Ji Hyun

AU - Kim, Eun Kyung

AU - Lee, Young Kyung

AU - Kim, Tae Hyung

AU - Kim, Woo Jin

AU - Lee, Jin Hwa

AU - Lee, Sang Min

AU - Lee, Sang Yeub

AU - Lim, Seong Yong

AU - Shin, Tae Rim

AU - Yoon, Ho Il

AU - Sheen, Seung Soo

AU - Oh, Yeon Mok

AU - Lee, Sang Do

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and responses to therapies are highly variable. The aim of this study was to identify the predictors of pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD. A total of 127 patients with stable COPD from the Korean Obstructive Lung Disease (KOLD) Cohort, which were prospectively recruited from June 2005 to September 2009, were analyzed retrospectively. The prediction models for the FEV1, FVC and IC/TLC changes after 3 months of treatment with salmeterol/fluticasone were constructed by using multiple, stepwise, linear regression analysis. The prediction model for the FEV1 change after 3 months of treatment included wheezing history, pre-bronchodilator FEV1, post-bronchodilator FEV1 change and emphysema extent on CT (R = 0.578). The prediction models for the FVC change after 3 months of treatment included prebronchodilator FVC, post-bronchodilator FVC change (R = 0.533), and those of IC/TLC change after 3 months of treatment did pre-bronchodilator IC/TLC and post-bronchodilator FEV1 change (R = 0.401). Wheezing history, pre-bronchodilator pulmonary function, bronchodilator responsiveness, and emphysema extent may be used for predicting the pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD.

AB - Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and responses to therapies are highly variable. The aim of this study was to identify the predictors of pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD. A total of 127 patients with stable COPD from the Korean Obstructive Lung Disease (KOLD) Cohort, which were prospectively recruited from June 2005 to September 2009, were analyzed retrospectively. The prediction models for the FEV1, FVC and IC/TLC changes after 3 months of treatment with salmeterol/fluticasone were constructed by using multiple, stepwise, linear regression analysis. The prediction model for the FEV1 change after 3 months of treatment included wheezing history, pre-bronchodilator FEV1, post-bronchodilator FEV1 change and emphysema extent on CT (R = 0.578). The prediction models for the FVC change after 3 months of treatment included prebronchodilator FVC, post-bronchodilator FVC change (R = 0.533), and those of IC/TLC change after 3 months of treatment did pre-bronchodilator IC/TLC and post-bronchodilator FEV1 change (R = 0.401). Wheezing history, pre-bronchodilator pulmonary function, bronchodilator responsiveness, and emphysema extent may be used for predicting the pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD.

KW - Adrenergic beta-Agonists

KW - Chronic obstructive

KW - Corticosteroids

KW - Emphysema

KW - Pulmonary disease

KW - Respiratory function tests

UR - http://www.scopus.com/inward/record.url?scp=79953757633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953757633&partnerID=8YFLogxK

U2 - 10.3346/jkms.2011.26.3.379

DO - 10.3346/jkms.2011.26.3.379

M3 - Article

C2 - 21394306

AN - SCOPUS:79953757633

VL - 26

SP - 379

EP - 385

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 3

ER -